Literature DB >> 27463232

The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation.

Nicola Alessio1, Servet Özcan2,3, Kazuki Tatsumi4,5, Ayşegül Murat3, Gianfranco Peluso6, Mari Dezawa5, Umberto Galderisi1,2,7.   

Abstract

Mesenchymal stromal cells (MSCs) are a heterogeneous population, which contain several cell phenotypes: mesenchymal stem cells, progenitor cells, fibroblasts and other type of cells. Previously, we identified unique stem cells that we named multilineage-differentiating stress enduring (Muse) cells as one to several percent of MSCs of the bone marrow, adipose tissue and dermis. Among different cell populations in MSCs, Muse cells, positive for pluripotent surface marker SSEA-3, may represent cells responsible for pluripotent-like property of MSCs, since they express pluripotency genes, able to differentiated into triploblastic cells from a single cells and are self-renewable. MSCs release biologically active factors that have profound effects on local cellular dynamics. A thorough examination of MSC secretome seems essential for understanding the physiological functions exerted by these cells in our organism and also for rational cellular therapy design. In this setting, studies on secretome of Muse cells may shed light on pathways that are associated with their specific features. Our findings evidenced that secretomes of MSCs and Muse cells contain factors that regulate extracellular matrix remodeling, ox-redox activities and immune system. Muse cells appear to secrete factors that may preserve their stem cell features, allow survival under stress conditions and may contribute to their immunomodulation capacity. In detail, the proteins belonging to protein kinase A signaling, FXR/RXR activation and LXR/RXR activation pathways may play a role in regulation of Muse stem cell features. These last 2 pathways together with proteins associated with antigen presentation pathway and coagulation system may play a role in immunomodulation.

Entities:  

Keywords:  Mesenchymal stem cells; apoptosis; cancer; secretome; senescence

Mesh:

Year:  2016        PMID: 27463232      PMCID: PMC5270533          DOI: 10.1080/15384101.2016.1211215

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  63 in total

1.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 2.  The role of serpins in vertebrate immunity.

Authors:  M S J Mangan; D Kaiserman; P I Bird
Journal:  Tissue Antigens       Date:  2008-05-20

Review 3.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

4.  Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production.

Authors:  Erin L Skornicka; Nadya Kiyatkina; Matthew C Weber; Mark L Tykocinski; Peter H Koo
Journal:  Cell Immunol       Date:  2004 Nov-Dec       Impact factor: 4.868

5.  Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells.

Authors:  Daniel L Coutu; Moïra François; Jacques Galipeau
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

6.  Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 expression: the role of the cAMP/PKA pathway.

Authors:  S Faherty; A Fitzgerald; M Keohan; L R Quinlan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-01       Impact factor: 2.416

7.  Peripheral nerve regeneration by the in vitro differentiated-human bone marrow stromal cells with Schwann cell property.

Authors:  Satoshi Shimizu; Masaaki Kitada; Hiroto Ishikawa; Yutaka Itokazu; Shohei Wakao; Mari Dezawa
Journal:  Biochem Biophys Res Commun       Date:  2007-06-08       Impact factor: 3.575

Review 8.  CRH: the link between hormonal-, metabolic- and behavioral responses to stress.

Authors:  Krisztina J Kovács
Journal:  J Chem Neuroanat       Date:  2013-06-15       Impact factor: 3.052

9.  Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells' osteogenic differentiation.

Authors:  I-Chun Tai; Yao-Hsien Wang; Chung-Hwan Chen; Shu-Chun Chuang; Je-Ken Chang; Mei-Ling Ho
Journal:  Int J Nanomedicine       Date:  2015-09-21

10.  GATA-3 regulates the self-renewal of long-term hematopoietic stem cells.

Authors:  Catherine Frelin; Robert Herrington; Salima Janmohamed; Mary Barbara; Gary Tran; Christopher J Paige; Patricia Benveniste; Juan-Carlos Zuñiga-Pflücker; Abdallah Souabni; Meinrad Busslinger; Norman N Iscove
Journal:  Nat Immunol       Date:  2013-08-25       Impact factor: 25.606

View more
  20 in total

1.  Clinical development of MUSE cell treatment: The challenges.

Authors:  Jan Stolk
Journal:  Cell Cycle       Date:  2016-08-30       Impact factor: 4.534

Review 2.  Human Mesenchymal Stem/Stromal Cells in Immune Regulation and Therapy.

Authors:  Éva Mezey
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

3.  High throughput screening of mesenchymal stem cell lines using deep learning.

Authors:  Gyuwon Kim; Jung Ho Jeon; Keonhyeok Park; Sung Won Kim; Do Hyun Kim; Seungchul Lee
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  The evaluation of the safety and efficacy of intravenously administered allogeneic multilineage-differentiating stress-enduring cells in a swine hepatectomy model.

Authors:  Masahiro Iseki; Masamichi Mizuma; Shohei Wakao; Yoshihiro Kushida; Katsuyoshi Kudo; Masahiko Fukase; Masaharu Ishida; Tomoyuki Ono; Mitsuhiro Shimura; Ichiro Ise; Yukie Suzuki; Teruko Sueta; Ryuta Asada; Shinobu Shimizu; Yoshiyuki Ueno; Mari Dezawa; Michiaki Unno
Journal:  Surg Today       Date:  2020-09-11       Impact factor: 2.549

5.  Beneficial Effects of Systemically Administered Human Muse Cells in Adriamycin Nephropathy.

Authors:  Nao Uchida; Yoshihiro Kushida; Masaaki Kitada; Shohei Wakao; Naonori Kumagai; Yasumasa Kuroda; Yoshiaki Kondo; Yukari Hirohara; Shigeo Kure; Gregorio Chazenbalk; Mari Dezawa
Journal:  J Am Soc Nephrol       Date:  2017-07-03       Impact factor: 10.121

6.  Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy.

Authors:  Toshihiko Suzuki; Yoshiaki Sato; Yoshihiro Kushida; Masahiro Tsuji; Shohei Wakao; Kazuto Ueda; Kenji Imai; Yukako Iitani; Shinobu Shimizu; Hideki Hida; Takashi Temma; Shigeyoshi Saito; Hidehiro Iida; Masaaki Mizuno; Yoshiyuki Takahashi; Mari Dezawa; Cesar V Borlongan; Masahiro Hayakawa
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-22       Impact factor: 6.200

Review 7.  Pluripotent nontumorigenic multilineage differentiating stress enduring cells (Muse cells): a seven-year retrospective.

Authors:  Samantha C Fisch; María L Gimeno; Julia D Phan; Ariel A Simerman; Daniel A Dumesic; Marcelo J Perone; Gregorio D Chazenbalk
Journal:  Stem Cell Res Ther       Date:  2017-10-18       Impact factor: 6.832

8.  Human Multilineage-differentiating Stress-Enduring Cells Exert Pleiotropic Effects to Ameliorate Acute Lung Ischemia-Reperfusion Injury in a Rat Model.

Authors:  Hiroshi Yabuki; Shohei Wakao; Yoshihiro Kushida; Mari Dezawa; Yoshinori Okada
Journal:  Cell Transplant       Date:  2018-04-30       Impact factor: 4.064

9.  Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting.

Authors:  Zikuan Leng; Dongming Sun; Zihao Huang; Iman Tadmori; Ning Chiang; Nikhit Kethidi; Ahmed Sabra; Yoshihiro Kushida; Yu-Show Fu; Mari Dezawa; Xijing He; Wise Young
Journal:  Cell Transplant       Date:  2019-04-18       Impact factor: 4.064

10.  Stress and stem cells: adult Muse cells tolerate extensive genotoxic stimuli better than mesenchymal stromal cells.

Authors:  Nicola Alessio; Tiziana Squillaro; Servet Özcan; Giovanni Di Bernardo; Massimo Venditti; Mariarosa Melone; Gianfranco Peluso; Umberto Galderisi
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.